Blog
RSS FeedPosted by Michael Wonder on 13 May 2020
Gilead’s remdesivir tested with other drugs to fight COVID-19
13 May 2020 - Researchers are looking to find a more potent coronavirus-fighting cocktail. ...
Posted by Michael Wonder on 12 May 2020
COVID-19 update: FDA takes new actions to accelerate development of novel prevention, treatment options for COVID-19
11 May 2020 - Today, the U.S. FDA took important actions to help accelerate the development of prevention and treatment options ...
Posted by Michael Wonder on 04 May 2020
How remdesivir, new hope for COVID-19 patients, was resurrected
4 May 2020 - The drug failed as a treatment for hepatitis and Ebola. With federal funding, scientists trained it on ...
Posted by Michael Wonder on 28 Apr 2020
The race for coronavirus vaccines: a graphical guide
28 April 2020 - Eight ways in which scientists hope to provide immunity to SARS-CoV-2. ...
Posted by Michael Wonder on 28 Apr 2020
In race for a coronavirus vaccine, an Oxford group leaps ahead
27 April 2020 - As scientists at the Jenner Institute prepare for mass clinical trials, new tests show their vaccine to ...
Posted by Michael Wonder on 27 Apr 2020
America needs to win the coronavirus vaccine race
26 April 2020 - Other countries might not be quick to share. Time to speed up trials and ramp up manufacturing ...
Posted by Michael Wonder on 23 Apr 2020
Bill Gates on how to fight future pandemics
23 April 2020 - The coronavirus will hasten three big medical breakthroughs. That is just a start. ...
Posted by Michael Wonder on 22 Apr 2020
Prediction models - development, evaluation and clinical application
23 April 2020 - When national lipid guidelines first incorporated a model based on data from the Framingham Heart Study — ...
Posted by Michael Wonder on 21 Apr 2020
Director of U.S. agency key to vaccine development leaves role suddenly amid coronavirus pandemic
21 April 2020 - Rick Bright, one of the nation’s leading vaccine development experts and the director of the Biomedical ...
Posted by Michael Wonder on 21 Apr 2020
Coronavirus puts big pharma’s IP regime to the test
21 April 2020 - “Chaotic” is how Jorge Contreras, a law professor at the University of Utah, describes a struggle ...
Posted by Michael Wonder on 21 Apr 2020
If pharma helps quench the COVID-19 pandemic, what will it want in return?
21 April 2020 - Make no mistake: the only long-term solution to the COVID-19 pandemic is a safe and effective ...
Posted by Michael Wonder on 20 Apr 2020
Novartis to sponsor large clinical trial of hydroxychloroquine in hospitalised COVID-19 patients
20 April 2020 - Novartis has reached an agreement with the US FDA to proceed with a Phase III clinical trial ...
Posted by Michael Wonder on 18 Apr 2020
NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options
17 April 2020 - The National Institutes of Health (NIH) and the Foundation for the NIH are bringing together more than ...
Posted by Michael Wonder on 17 Apr 2020
The coronavirus is mutating. What does that mean for a vaccine?
16 April 2020 - Around the world, hope for a return to normalcy is pinned on a vaccine, the “ultimate ...
Posted by Michael Wonder on 16 Apr 2020
Can the world find a good COVID-19 vaccine quickly enough?
16 April 2020 - And can it mass produce it fairly if it does? ...